国药控股(01099)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01099 国药控股

已收盘 12-05 16:09:08

20.560

+0.100

+0.49%

最高20.560	最低20.280	成交量510.61万
今开20.400	昨收20.460	日振幅1.37%
总市值641.68亿	流通市值275.88亿	总股本31.21亿
成交额1.05亿	换手率0.38%	流通股本13.42亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01099","market":"HK","secType":"STK","nameCN":"国药控股","latestPrice":20.56,"timestamp":1764922148003,"preClose":20.46,"halted":0,"volume":5106064,"delay":0,"floatShares":1341810740,"shares":3121000000,"eps":2.4883067421702876,"marketStatus":"已收盘","change":0.1,"latestTime":"12-05 16:09:08","open":20.4,"high":20.56,"low":20.28,"amount":104652790,"amplitude":0.013685,"askPrice":20.56,"askSize":23600,"bidPrice":20.52,"bidSize":22000,"shortable":3,"etf":0,"ttmEps":2.499332213276451,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":5,"adr":0,"listingDate":1253635200000,"exchange":"SEHK","adjPreClose":20.46,"dividendRate":0.036417,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":1.445194,"lotSize":400,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SNP.HK","impliedVol":0.222,"impliedVolPercentile":0.0569},"requestUrl":"/m/hq/s/01099","defaultTab":"news","newsList":[{"id":"2589402852","title":"【券商聚焦】交银国际：医药行业短期催化剂充足 长期继续看好创新主线","url":"https://stock-news.laohu8.com/highlight/detail?id=2589402852","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589402852?lang=zh_cn&edition=full","pubTime":"2025-12-05 10:38","pubTimestamp":1764902337,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示，2025年10月以来，内资通过港股通持有医药股的比例小幅下降，外资持仓从年中起亦呈回落态势，但内外资加大创新药布局的大方向不变。而外资则更积极，聚焦创新主线中的龙头及产业链上游，包括恒瑞医药、君实生物和荣昌生物等创新药，及康龙化成、药明康德和泰格医药等CXO标的。12月，行业仍有充足催化剂，包括各项学术大会、医保谈判结果公布、美联储潜在降息等，板块投资情绪有望稳中有升。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970976","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B543WZ88.USD","LU1251922891.USD","01099","BK1197","BK1500","LU0634319403.HKD","LU1969619763.USD","LU2476274720.SGD","01789","LU0640798160.USD","LU0348766576.USD","IE00BPRC5H50.USD","01530","LU0540923850.HKD","BK1588","LU2476274308.USD","LU0417516571.SGD","BK1585","LU0417516902.SGD","BK1593","BK1141","03329","IE00B5MMRT66.SGD","LU2488822045.USD","LU1303224171.USD","LU2328871848.SGD","09688","LU0348825331.USD","LU2778985437.USD","BK1617","BK1147","02228","BK1583","SG9999014674.SGD","LU2399975544.HKD","LU0417516738.SGD","03933","02367","LU0348827113.USD","02268","LU1794554557.SGD","BK1161","02196","SG9999004311.SGD","LU0588546209.SGD","LU1770034418.SGD","LU0561508036.HKD","06160","09926","HK0000165453.HKD"],"gpt_icon":0},{"id":"2589834810","title":"122亿！国药控股大合作来了","url":"https://stock-news.laohu8.com/highlight/detail?id=2589834810","media":"赛柏蓝","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589834810?lang=zh_cn&edition=full","pubTime":"2025-12-04 18:33","pubTimestamp":1764844407,"startTime":"0","endTime":"0","summary":"01国药控股再次牵手复宏汉霖12月3日，复宏汉霖消息称，将重续与国药控股经销合作，合作期限为2026年1月1日至2028年12月31日。2023年-2025年9月，国药控股分别完成了19.17亿元、20.40亿元以及16.93亿元的销售额。在此背景下，国药控股与复宏汉霖再次达成合作，未来三年的产品销售总额上限高达122.24亿元。12月2日，国药控股官方微信消息称，近日与皮尔法伯制药进行了战略合作签约。在2025年上半年时，国药控股营收和归母净利润较同期分别下降2.95%和6.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204204517a723d0b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204204517a723d0b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1115378108.SGD","02696","HK0000165453.HKD","LU0640798160.USD","BK1500","BK1161","BK1515","BK1197","01099"],"gpt_icon":0},{"id":"1131409240","title":"国药控股（01099）更新2025年11月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1131409240","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131409240?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:58","pubTimestamp":1764838731,"startTime":"0","endTime":"0","summary":"国药控股股份有限公司（01099）于2025年12月4日递交2025年11月股份变动月报表。公告显示，截至报告期末（2025年11月30日），公司H股和内资股的已发行及注册股本均无增减变动，股本结构维持不变。\n具体来看，H股于本月末保持1,341,810,740股，内资股于本月末保持1,778,845,451股，总股本规模为人民币3,120,656,191元。公告中提及的股份期权、可换股票据等方面均无新增或变动事项，当月未发生任何购回或注销活动。\n公司在公告中表示将继续遵守香港联交所《上市规则》及相关法律法规，此次月报表由公司秘书吴壹建签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"gpt_icon":0},{"id":"2588207135","title":"复宏汉霖重续与国药控股经销协议 年度上限逐年递增","url":"https://stock-news.laohu8.com/highlight/detail?id=2588207135","media":"财中社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588207135?lang=zh_cn&edition=full","pubTime":"2025-12-04 09:59","pubTimestamp":1764813590,"startTime":"0","endTime":"0","summary":"12月3日，复宏汉霖（02696）发布公告，宣布与国药控股的经销框架协议（2025重续）已达成，该协议的初始期限自2023年1月1日起至2025年12月31日止，现已自动续期三年，新的协议有效期自2026年1月1日至2028年12月31日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512043582422282.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02696","BK1197","HK0000165453.HKD","LU0640798160.USD","BK1515","01099","BK1500","LU1115378108.SGD"],"gpt_icon":0},{"id":"2588075008","title":"每日卖空追踪 | 国药控股 12月03日卖空量成交18.04万股，卖空比例为6.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588075008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588075008?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:30","pubTimestamp":1764750617,"startTime":"0","endTime":"0","summary":"国药控股北京时间12月03日，跌0.59%，卖空量成交18.04万股，较上一交易日减少65.68%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。港股数据实时性强，适合短线跟踪；美股因T+2延迟，更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163236a7210d16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163236a7210d16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0640798160.USD","LU1115378108.SGD","BK1515","BK1197","01099","BK1500"],"gpt_icon":0},{"id":"2588008073","title":"公司问答丨禾元生物：公司已与国药控股、贝达药业等多家药品经销商签订经销协议 完成全国30余个省市区域的销售网络布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2588008073","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588008073?lang=zh_cn&edition=full","pubTime":"2025-12-03 15:51","pubTimestamp":1764748315,"startTime":"0","endTime":"0","summary":"格隆汇12月3日｜有投资者在互动平台向禾元生物提问：公司和国药控股的合作中，国药控股是作为合同指定区域的独家代理，负责指定区域的药品销售，还是只是负责指定区域的药品配送，药品的销售推广是由公司自己负责推销？这和贝达药业的合作模式是一样的吗？ 禾元生物回复称，公司已与国药控股、贝达药业等多家药品经销商签订经销协议，完成了全国30余个省市区域的销售网络布局。国药控股是公司在特定区域的商业化合作伙伴。双方正在积极开展产品的学术推广、市场拓展及渠道建设等相关工作，共同推动产品的市场覆盖和临床应用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203155303a720f5a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203155303a720f5a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1115378108.SGD","BK1515","01099","BK1197","BK1500","91287","LU0640798160.USD"],"gpt_icon":0},{"id":"2588982093","title":"每日卖空追踪 | 国药控股 12月02日卖空量成交30.12万股，卖空比例为5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588982093","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588982093?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:30","pubTimestamp":1764664216,"startTime":"0","endTime":"0","summary":"国药控股北京时间12月02日，涨0.29%，卖空量成交30.12万股，较上一交易日减少71.74%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。港股数据实时性强，适合短线跟踪；美股因T+2延迟，更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202163215978b6435&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202163215978b6435&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1500","01099","LU1115378108.SGD","BK1197","BK1515","LU0640798160.USD"],"gpt_icon":0},{"id":"2588309393","title":"国药控股12月02日主力净流入1172.7万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2588309393","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588309393?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:15","pubTimestamp":1764663344,"startTime":"0","endTime":"0","summary":"12月02日, 国药控股股价涨0.29%，报收20.50元，成交金额1.1亿元，换手率0.39%，振幅2.74%，量比1.55。国药控股今日主力资金净流入1172.7万元，上一交易日主力净流出272.4万元。该股近5个交易日上涨0.59%，主力资金累计净流入1332.7万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1.3亿元，其中净流入天数为14日。该股主力净额占比0.04%，港股市场排名138/2683。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120216193495265120&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120216193495265120&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1115378108.SGD","01099","LU0640798160.USD","BK1515","BK1500","BK1197"],"gpt_icon":0},{"id":"2588087002","title":"上任一年多即离场 国药控股董事长辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2588087002","media":"经济参考网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588087002?lang=zh_cn&edition=full","pubTime":"2025-12-02 15:09","pubTimestamp":1764659355,"startTime":"0","endTime":"0","summary":"近日，国药控股股份有限公司（证券简称：国药控股，证券代码：01099.Hk）发布公告，由于工作安排原因，赵炳祥已向董事会提出辞任非执行董事、董事会董事长等职务，冯蓉丽辞去非执行董事等职务。值得一提的是，赵炳祥自2024年9月上任公司董事长一职，至今仅一年多时间，期间公司业绩承压。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512023580306748.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1500","LU0640798160.USD","BK1197","LU1115378108.SGD","BK1515","01099"],"gpt_icon":0},{"id":"2588093980","title":"法伯精诚 国药匠心——国药控股与皮尔法伯制药达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2588093980","media":"国药控股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588093980?lang=zh_cn&edition=full","pubTime":"2025-12-02 10:17","pubTimestamp":1764641863,"startTime":"0","endTime":"0","summary":"近日，国药控股与皮尔法伯制药在国药控股大厦举行战略合作签约仪式。国药控股执行董事、总裁连万勇于午宴致辞中表示，国药控股非常高兴能与皮尔法伯制药这样的国际领先企业达成战略合作。与国药控股这一行业巨头建立战略伙伴关系，是其深耕中国市场的重要里程碑。国药控股无与伦比的渠道覆盖和市场领导力，将极大提升皮尔法伯制药产品的可及性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202110846a4c70836&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202110846a4c70836&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","BK1500","LU0640798160.USD","BK1574","BK1191","01099","BK1197","LU1115378108.SGD","BK1515"],"gpt_icon":0},{"id":"2588667719","title":"医保职业骗保产业链被曝光；国药控股高管调整","url":"https://stock-news.laohu8.com/highlight/detail?id=2588667719","media":"21世纪经济报道","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588667719?lang=zh_cn&edition=full","pubTime":"2025-12-01 08:02","pubTimestamp":1764547330,"startTime":"0","endTime":"0","summary":"国家医保局发文曝光医保职业骗保产业链国家医保局官微发文显示，上海有关部门从一起超量配药案件入手，最终斩断了一条医保职业骗保产业链。经查，从2023年至2024年7月，王某以非法占有为目的，持本人及亲友医保卡至本市多家医院多配本人自用药以外药品，后出售牟利，导致国家医保基金损失，其行为已经触犯了法律。近日，松江检察院以涉嫌诈骗罪对王某提起公诉。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512013578555582.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512013578555582.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01099","BK1515","BK1500","LU1115378108.SGD","LU0640798160.USD","BK1197"],"gpt_icon":0},{"id":"2587799797","title":"国药控股董事长赵炳祥辞任，晋斌拟接任","url":"https://stock-news.laohu8.com/highlight/detail?id=2587799797","media":"财中社","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587799797?lang=zh_cn&edition=full","pubTime":"2025-11-30 17:34","pubTimestamp":1764495254,"startTime":"0","endTime":"0","summary":"11月28日，国药控股（01099）发布公告，宣布非执行董事、董事长及授权代表赵炳祥因工作安排原因辞任，辞任同时还有非执行董事冯蓉丽。同时，董事会提议任命晋斌和李莹为非执行董事，任命需经股东大会批准后生效。晋斌将担任董事长及授权代表，此外，他还将担任提名委员会主席、战略与投资委员会主席及法律合规与环境、社会及治理委员会委员，任职同样需待股东大会批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511303578445386.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1115378108.SGD","BK1515","BK1500","LU0640798160.USD","BK1197","01099"],"gpt_icon":0},{"id":"2586728733","title":"国药控股(01099)：建议委任晋斌及李莹为非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2586728733","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586728733?lang=zh_cn&edition=full","pubTime":"2025-11-28 22:51","pubTimestamp":1764341515,"startTime":"0","endTime":"0","summary":"于同日，董事会决议建议委任晋斌先生及李莹女士为非执行董事。董事会谨此宣布，于2025年11月28日，董事会决议选举晋先生担任董事长及授权代表职务。晋先生作为董事长及授权代表的任职须待股东于公司股东大会上批准其非执行董事的委任后方可生效。董事会进一步宣布，于2025年11月28日，董事会决议选举晋先生担任提名委员会主席、战略与投资委员会主席及法律合规与环境、社会及治理委员会委员。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375558.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1197","01099","BK1515","BK1500","LU1115378108.SGD","LU0640798160.USD"],"gpt_icon":0},{"id":"2586226628","title":"每日卖空追踪 | 国药控股 11月27日卖空量成交25.32万股，卖空比例为9.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586226628","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586226628?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:30","pubTimestamp":1764232216,"startTime":"0","endTime":"0","summary":"国药控股北京时间11月27日，跌0.69%，卖空量成交25.32万股，较上一交易日减少38.84%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。港股数据实时性强，适合短线跟踪；美股因T+2延迟，更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127163419a4bdad4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127163419a4bdad4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1197","BK1500","LU0640798160.USD","BK1515","LU1115378108.SGD","01099"],"gpt_icon":0},{"id":"2586325921","title":"摩根大通增持国药控股(01099)约210.48万股 每股作价约20.11港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586325921","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586325921?lang=zh_cn&edition=full","pubTime":"2025-11-26 19:20","pubTimestamp":1764156047,"startTime":"0","endTime":"0","summary":"香港联交所最新数据显示，11月21日，‌摩根大通增持国药控股(01099)210.4841万股，每股作价20.1147港元，总金额约为4233.82万港元。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20251126/20251126192126_85167.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251126/20251126192126_85167.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374049.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"摩根大通增持国药控股(01099)约210.48万股 每股作价约20.11港元","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["IE00BWXC8680.SGD","IE00BN8TJ469.HKD","LU0234572021.USD","LU0345770308.USD","LU0787776722.HKD","LU2264538146.SGD","IE00BFXG1179.USD","IE00B775SV38.USD","LU0820562030.AUD","LU0211326839.USD","LU0320765489.SGD","BK1500","IE000M9KFDE8.USD","LU2106854487.HKD","IE00BLSP4239.USD","LU0211327993.USD","LU0345770993.USD","BK4566","LU2756315318.SGD","BK1197","LU1084165304.USD","LU0211326755.USD","LU1551013425.SGD","LU0170899867.USD","LU1244550577.SGD","IE00BKVL7J92.USD","LU2430703095.HKD","LU1670627923.USD","LU0683600562.USD","IE00BZ1G4Q59.USD","LU0106261372.USD","LU1629891620.HKD","LU2756315664.SGD","LU0006306889.USD","LU0251132253.USD","LU0345769631.USD","LU2746668461.USD","LU2430703178.SGD","LU2430703251.USD","LU1720051108.HKD","IE00BBT3K403.USD","LU1548497426.USD","BK4207","LU0106831901.USD","LU1363072403.SGD","BK4504","LU1267930490.SGD","01099","IE00BHPRN162.USD","BK1515"],"gpt_icon":0},{"id":"2585164751","title":"每日卖空追踪 | 国药控股 11月21日卖空量成交79.64万股，卖空比例为13.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585164751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585164751?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:30","pubTimestamp":1763713820,"startTime":"0","endTime":"0","summary":"国药控股北京时间11月21日，跌2.72%，卖空量成交79.64万股，较上一交易日减少14.4%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。港股数据实时性强，适合短线跟踪；美股因T+2延迟，更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121163226a4b12759&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121163226a4b12759&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0640798160.USD","LU1115378108.SGD","BK1197","BK1500","01099","BK1515"],"gpt_icon":0},{"id":"2585152823","title":"每日卖空追踪 | 国药控股 11月20日卖空量成交55.96万股，卖空比例为16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585152823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585152823?lang=zh_cn&edition=full","pubTime":"2025-11-20 16:30","pubTimestamp":1763627418,"startTime":"0","endTime":"0","summary":"国药控股北京时间11月20日，涨0.98%，卖空量成交55.96万股，较上一交易日减少54.22%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。港股数据实时性强，适合短线跟踪；美股因T+2延迟，更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120163400a7064656&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120163400a7064656&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01099","BK1515","LU1115378108.SGD","BK1500","LU0640798160.USD","BK1197"],"gpt_icon":0},{"id":"2585152834","title":"复星旗下健嘉医疗的45%股权，国药控股以6.3亿挂牌转让","url":"https://stock-news.laohu8.com/highlight/detail?id=2585152834","media":"新浪财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585152834?lang=zh_cn&edition=full","pubTime":"2025-11-20 13:05","pubTimestamp":1763615100,"startTime":"0","endTime":"0","summary":"11月14日，北京市产权交易所发布了一项股权转让项目，转让方为国药控股股份有限公司，转让标的为健嘉医疗投资管理有限公司45%股权，挂牌价格为6.3亿元。健嘉医疗原名国控医疗，是2013年国药控股和复星医药共同出资成立的，注册资金10亿元，据称是国药控股下属唯一专业从事医疗机构投资与运营管理的平台。根据复星医药2023年年报，2023年10月，复星医药以1.2亿元资金增持国控医疗6%的股权，持股比例增至51%，实现控股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511201419589774fd65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511201419589774fd65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01099","BK1197","BK1500","BK1515","LU0640798160.USD","LU1115378108.SGD"],"gpt_icon":0},{"id":"2584902516","title":"医药产业开始“大洗牌”","url":"https://stock-news.laohu8.com/highlight/detail?id=2584902516","media":"赛柏蓝","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584902516?lang=zh_cn&edition=full","pubTime":"2025-11-20 11:23","pubTimestamp":1763608982,"startTime":"0","endTime":"0","summary":"医药产业整合加剧。至少14家亏损药企被出售近日，国药控股在北京产权交易所公开挂牌，出售健嘉医疗投资管理有限公司45%股权，转让底价高达6.3亿元。虽整体态势未能扭转，但王学恭表示，创新药商业化成为了医药产业增长主要动能。会上，相关专家预测，医药产业整体增速将进一步放缓。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511201125469774bc26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511201125469774bc26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0640798160.USD","06978","BK1197","BK1161","BK1500","02196","01099","BK1574","BK1515","01801","LU1115378108.SGD"],"gpt_icon":0},{"id":"2584908274","title":"【券商聚焦】中信建投：医药流通行业收入端稳健向好 关注回款及“十五五”规划","url":"https://stock-news.laohu8.com/highlight/detail?id=2584908274","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584908274?lang=zh_cn&edition=full","pubTime":"2025-11-20 09:20","pubTimestamp":1763601625,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投研报指，中药行业短期基数压力有望缓解，渠道库存加速出清，看好年底需求回暖，及后续基本面和估值改善机会；创新领域有助构建第二增长曲线，中药消费品公司品牌延展空间广阔。血制品行业关注“十五五”浆站建设规划及行业并购整合进展，需求端看好静丙、因子类产品需求端提升及新品研发。疫苗行业关注重磅产品销售改善情况及创新管线研发进展，政策出台及疫苗出海有望推动企业进一步发展。医药零售行业转型变革稳步推进，关注后续多元催化。医药流通行业收入端稳健向好，关注回款及“十五五”规划。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/YmUwNDEzZDkyZTQxMjdjZGQ1ZTFlYjEwODUyNTc4Njg4Nw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/YmUwNDEzZDkyZTQxMjdjZGQ1ZTFlYjEwODUyNTc4Njg4Nw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1969973","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348767384.USD","LU0640798160.USD","BK1585","LU0417516571.SGD","BK1574","01789","LU0561508036.HKD","LU2476274308.USD","BK0276","LU1961090484.USD","03933","LU0348825331.USD","LU0588546209.SGD","159938","01099","LU1251922891.USD","BK1583","LU0417516738.SGD","02196","09939","IE00BPRC5H50.USD","LU2488822045.USD","BK1161","BK1100","IE00B543WZ88.USD","LU2476274720.SGD","02268","LU1303224171.USD","LU2399975544.HKD","BK1191","02367","LU1969619763.USD","BK1593","BK1515","LU0540923850.HKD","LU0307460666.USD","01530","LU1719994722.HKD","06160","LU0348766576.USD","09688","02228","LU2328871848.SGD","09926","601066","BK1197","BK1500","BK1617","IE00B5MMRT66.SGD","LU0417516902.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinopharmgroup.com.cn","stockEarnings":[{"period":"1week","weight":0.0109},{"period":"1month","weight":0.0541},{"period":"3month","weight":0.1024},{"period":"6month","weight":0.1391},{"period":"1year","weight":0.0157},{"period":"ytd","weight":-0.001}],"compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":-0.0006},{"period":"3month","weight":0.0204},{"period":"6month","weight":0.0901},{"period":"1year","weight":0.3137},{"period":"ytd","weight":0.2929}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"国药控股股份有限公司是一家主要从事药品、医疗保健产品及医疗器械批发和零售业务的中国公司。该公司通过四个部门运营业务。医药分销部门为国内外药品及保健品制造商及其他供货商提供分销、物流及其他加值服务。器械分销部门向客户分销医疗器材。医药零售业务部门拥有直接经营或特许经营的零售药局网路。其他业务部门从事药品、化学试剂及实验室用品的制造与销售。","yearOnYearQuotes":[{"month":1,"riseRate":0.5625,"avgChangeRate":0.000304},{"month":2,"riseRate":0.5625,"avgChangeRate":0.030473},{"month":3,"riseRate":0.5,"avgChangeRate":0.010225},{"month":4,"riseRate":0.4375,"avgChangeRate":0.022869},{"month":5,"riseRate":0.625,"avgChangeRate":-0.004548},{"month":6,"riseRate":0.4375,"avgChangeRate":-0.005852},{"month":7,"riseRate":0.5,"avgChangeRate":-0.015111},{"month":8,"riseRate":0.4375,"avgChangeRate":0.012101},{"month":9,"riseRate":0.4375,"avgChangeRate":-0.011177},{"month":10,"riseRate":0.647059,"avgChangeRate":0.042295},{"month":11,"riseRate":0.470588,"avgChangeRate":-0.007287},{"month":12,"riseRate":0.588235,"avgChangeRate":-0.001128}],"exchange":"SEHK","name":"国药控股","nameEN":"SINOPHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药控股(01099)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药控股(01099)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药控股,01099,国药控股股票,国药控股股票老虎,国药控股股票老虎国际,国药控股行情,国药控股股票行情,国药控股股价,国药控股股市,国药控股股票价格,国药控股股票交易,国药控股股票购买,国药控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药控股(01099)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药控股(01099)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}